Alprolix

eftrenonacog alfa · Swedish Orphan Biovitrum AB (Sobi)

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for Alprolix, covering 2024-09-19 to 2026-07-06. Get the full timeline:

Most recent: EMA Authorised: Alprolix (eftrenonacog alfa) — Swedish Orphan Biovitrum AB (publ)